D Penicillamine comes back in the market - Medical Voice of eMediNews eIMANews works!
Dear All September 13, we raised the issue of shortage of D Penicillamine. Patients with Wilson disease (copper overload) with liver, neurological and psychiatric manifestations are treated with D-penicillamine.
D-penicillamine is an excellent chelator and patients have to be on this drug lifelong because of the genetic nature of the disease.
Since the last 6 months 3-4 different companies in India that were producing the drug had stopped production of D-penicillamine (Brand names CILAMIN or ARTAMINE 250 mg).
It appeared that the raw material that was coming from China was no longer available. Patients particularly children and adolescents and young adults are the most affected.
Our voice was listened to . Panacea Biotec one of the manufacturer has ensured limited availability of Life Saving Drug Cilamin 250 Capsule (D-Penicillamine IP 250 mg)
Cilamin 250 Capsule used for treatment of Wilsons disease, Rheumatoid Arthritis and other conditions witnessed short supply in the market during the last few months due to non-availability of raw material D-Penicillamine in India.
